US Patent Issued to Cardea Bio on July 1 for "Integrated circuit with 2D FETs for direct and indirect target signal measurement" (California Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,345,677, issued on July 1, was assigned to Cardea Bio Inc. (San Diego).

"Integrated circuit with 2D FETs for direct and indirect target signal measurement" was invented by Kiana Aran (Pasadena, Calif.), Brett Goldsmith (San Diego), Alexander Kane (Santa Cruz, Calif.) and Regis Peytavi (Costa Mesa, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A system and apparatus for direct or indirect target substance signal measurement include an integrated circuit with an array of 2D FETs with corresponding 2D transistor channels and a gate area for receiving a volume of liquid with one or more chemical or biological target substances, a conductive source el...